Skip to main content
Account
Fig. 7 | BMC Medical Imaging

Fig. 7

From: An ultrasound-based model for predicting the response to neoadjuvant chemotherapy in early stage triple negative breast cancer patients

Fig. 7

DCA of the nomogram. DCA of the nomogram suggests its utility in predicting pCR in patients with TNBC. Specifically, when a patient’s threshold probability falls within the range of 0.12–0.63, utilizing the nomogram offers a greater benefit compared to treating all or treating none approach of the patients. pCR, pathologic complete response; DCA, decision curve analysis

Back to article page